A VEGFR targeting peptide-drug conjugate (PDC) suppresses tumor angiogenesis in a TACE model for hepatocellular carcinoma therapy
oleh: Dongyuan Wang, Jiacheng Liu, Tongqiang Li, Yingliang Wang, Xiaoming Liu, Yaowei Bai, Chaoyang Wang, Shuguang Ju, Songjiang Huang, Chongtu Yang, Chen Zhou, Yu Zhang, Bin Xiong
| Format: | Article |
|---|---|
| Diterbitkan: | Nature Publishing Group 2022-10-01 |
Deskripsi
Schematic presentation of the design of VEGFR targeting peptide conjugate (QR-KLU) and the antineoplastic efficacy of peptide QR-KLU in vitro and in vivo.